Therapeutic effect of recombinant adenovirus encoding interferon-γ in a murine model of progressive pulmonary tuberculosis

Molecular Therapy

Volumn 16, Issue 6, 2008, Pages 1065-1072

  Mata Espinosa, Dulce A ^a,b   Mendoza Rodríguez, Valentin ^b   Aguilar León, Diana ^a   Rosales, Ricardo ^c   López Casillas, Fernando ^b   Hernández Pando, Rogelio ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACILLI; BACTERIAL STRAIN; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG MEGADOSE; DRUG POTENTIATION; GENE EXPRESSION; GENE THERAPY; HISTOPATHOLOGY; IMMUNOGENETICS; LOW DRUG DOSE; LUNG GRANULOMA; LUNG TUBERCULOSIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMONIA; SINGLE DRUG DOSE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALIA; BACILLI (CLASS); MURINAE; MUS;

EID: 44349157958     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.69     Document Type: Article

References (41)

1. North, RJ and Jung, YJ (2004). Immunity to tuberculosis. Annu Rev Immunol 22: 599-623.
2. Flynn, JL and Chan, J (2001). Immunology of tuberculosis. Annu Rev Immunol 19: 93-129.
3. Young, D, Hussell, T and Dougan, G (2002). Chronic bacterial infections: living with unwanted guests. Nat Immunol 3: 1026-1032.
4. Boehm, U, Klamp, T, Groot, M and Howard, JC (1997). Cellular responses to interferon-γ. Annu Rev Immunol 15: 749-795.
5. Dorman, SE and Holland, SM (2000). Interferon-γ and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 11: 321-333.
6. Dalton, DK, Pitts-Meek, S, Keshav, S, Figari, IS, Bradley, A and Stewart, TA (1993). Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259: 1739-1742.
7. Huang, S, Hendriks, W, Althage, A, Hemmi, S, Bluethmann, H, Kamijo, R et al. (1993). Immune response in mice that lack the interferon-? receptor. Science 259: 1742-1745.
8. Bogdan, C (2001). Nitric oxide and the immune response. Nat Immunol 2: 907-916.
9. Cooper, AM, Dalton, DK, Stewart, TA, Griffin, JP, Russell, DG and Orme, IM (1993). Disseminated tuberculosis in interferon-? gene-disrupted mice. J Exp Med 178: 2243-2247.
10. Flynn, JL, Chan, J, Triebold, KJ, Dalton, DK, Stewart, TA and Bloom, BR (1993). An essential role for interferon ? in resistance to Mycobacterium tuberculosis infection. J Exp Med 178: 2249-2254.
11. Baldwin, AS Jr. (1996). The NF-κB and I?B proteins: New discoveries and insights. Annu Rev Immunol 14: 649-683.
12. Lei, D, Lancaster, JR Jr, Joshi, MS, Nelson, S, Stoltz, D, Bagby, GJ et al. (1997). Activation of alveolar macrophages and lung host defenses using transfer of the interferon-γ gene. Am J Physiol 272: L852-L859.
13. Skerrett, SJ and Martin, TR (1994). Intratracheal interferon-γ augments pulmonary defenses in experimental legionellosis. Am J Respir Crit Care Med 149: 50-58.
14. Steinmüller, C, Franke-Ullmann, G, Lohnmann-Matthes, ML and Emmendörffer, A. (2000). Local activation of nonspecific defense against a respiratory model infection by application of interferon-γ: comparison between rat alveolar and interstitial lung macrophages. Am J Respir Cell Mol Biol 22: 481-490.
15. Smith-Jones, PM, Linkesch, W and Virgolini, I (1997). Interferon-γ for respiratory diseases. Lancet 350: 524.
16. Koh, WJ, Kwon, OJ, Suh, GY, Chung, MP, Kim, H, Lee, NY et al. (2004). Six-month therapy with aerosolized interferon-γ for refractory multidrug-resistant pulmonary tuberculosis. J Korean Med Sci 19 167-171.
17. Condos, R, Rom, WN and Schluger, NW (1997). Treatment of multi-drug resistant pulmonary tuberculosis with interferon-γ via aerosol. Lancet 349: 1513-1515.
18. Suárez-Méndez, R, García-García, I, Fernández-Olivera, N, Valdés-Quintana, M, Milanés-Virelles, MT, Carbonell, D et al. Adjuvant interferon γ in patients with drug-resistant pulmonary tuberculosis: A pilot study. (2004). BMC Infect Dis 4: 44.
19. Hallstrand, TS, Ochs, HD, Zhu, Q and Liles, WC (2004). Inhaled IFN-γ for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-γ deficiency. Eur Respir J 24: 367-370.
20. Graham, FL (2000). Adenovirus vectors for high-efficiency gene transfer into mammalian cells. Immunol Today 21: 426-428.
21. Tatsis, N and Ertl, HC (2004). Adenoviruses as vaccine vectors. Mol Ther 10: 616-629.
22. Rook, GA, Dheda, K and Zumla, A (2005). Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting? Vaccine 23: 2115-2120.
23. Hernández-Pando, R, Orozcoe, H, Sampieri, A, Pavón, L, Velasquillo, C, Larriva-Sahd, J et al. (1996). Correlation between kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology 89: 26-33.
24. Hernández-Pando, R, Orozco, EH, Arriaga, AK, Sampieri, A, Larriva-Sahd, J and Madrid, MV (1997). Analysis of the local kinetics and localization of interleukin-1α, tumor necrosis factor-α and transforming growth factor-β, during the course of experimental pulmonary tuberculosis. Immunology 90: 607-617.
25. Hernandez-Pando, R, Schön, T, Orozco, EH, Serafín, J and Estrada-García, I (2001). Expression of inducible nitric oxide synthase and nitrotyrosine during the evolution of experimental pulmonary tuberculosis. Exp Toxicol Pathol 53: 257-265.
26. Gao, Z, Kang, Y, Xu, Y, Shang, Y, Gai, J and He, Q (2002). Inhibition of allergic responsiveness in a murine asthma model via IFN-? transgene expression. Chin Med J (Engl) 115: 1470-1474.
27. He, TC, Zhou, S, da Costa, LT, Yu, J, Kinzler, KW and Vogelstein, B (1998). A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95: 2509-2514.
28. Cooper, AM, Adams, LB, Dalton, DK, Appelberg, R and Ehlers, S (2002). IFN-γ and NO mycobacterial disease: New jobs for old hands. Trends Microbiol 10: 221-226.
29. Mühl, H and Pfeilschifter, J (2003). Anti-inflammatory properties of pro-inflammatory interferon-γ. Int Immunopharmacol 3: 1247-1255.
30. Hernández-Pando, R, Aguilar-Leon, D, Orozco, H, Serrano, A, Ahlem, C, Trauger, R et al. (2005). 16-α-Bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis. J Infect Dis 191: 299-306.
31. Hernandez-Pando, R, Pavön, L, Arriaga, K, Orozco, H, Madrid-Marina, V and Rook, G (1997). Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection. Infect Immun 6: 84-90.
32. Rook, GA, Lowrie, D and Hernandez-Pando, R (2007). Immunotherapeutics for tuberculosis in experimental animals: Is there a common pathway activated by effective protocols. J Infect Dis 196: 191-198.
33. Kindler, V, Sappino, AP, Grau, GE, Piguet, PF and Vassalli, P (1989). The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56: 731-740.
34. Condos, R, Raju, B, Canova, A, Zhao, BY, Weiden, M, Rom, WN et al. (2003). Recombinant γ interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients. Infect Immun 71: 2058-2064.
35. Raju, B, Hoshino, Y, Kuwabara, K, Belitskaya, I, Prabhakar, S, Canova, A et al. (2004). Aerolized γ interferon (IFN-γ) induces expression of the genes encoding the IFN-γ-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis. Infect Immun 72: 1275-1283.
36. World Health Organization (2005). The WHO/IUATLD Global project on anti-tuberculosis drug resistance surveillance 1999-2002. World Health Organization: Geneva, Switzerland.
37. Varga, CM, Wickham, TJ and Lauffenburger, DA (2000). Receptor-mediated targeting of gene delivery vectors: Insights from molecular mechanisms for improved vehicle design. Biotechnol Bioeng 70: 593-605.
38. Gray, PW and Goeddel, DV (1983). Cloning and expression of murine immune interferon cDNA. Proc Natl Acad Sci USA 80: 5842-5846.
39. Seed, B and Aruffo, A (1987). Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc Natl Acad Sci USA 84: 3365-3369.
40. Jarnagin, JL and Luchsinger, DW (1980). The use of fluorescein diacetate and ethidium bromide as a stain for evaluating viability of mycobacteria. Stain Technol 55: 253-258.
41. Pedroza-González, A, García-Romo, GS, Aguilar-León, D, Calderón-Amador, J, Hurtado-Ortiz, R, Orozco-Estevez, H et al. (2004). In situ analysis of lung antigen-presenting cells during murine pulmonary infection with virulent Mycobacterium tuberculosis. Int J Exp Pathol 85: 135-145.